Related Experiment Video
Updated: May 10, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
MicroRNAs in peripheral artery disease
Toshio Imanishi1, Takashi Akasaka
1Department of Cardiovascular Medicine, Wakayama Medical University, Japan. t-imani@wakayama-med.ac.jp
Abstract:
Peripheral arterial disease (PAD) is due to diffuse atherosclerosis. The pathological process is characterized mainly by the aberrant proliferation of vascular smooth muscle cells and the formation of neointimal lesions. MicroRNAs (miRNAs) are highly conserved non-coding small RNA molecules that regulate a large fraction of the genome by binding to complementary mRNA sequences, resulting in post-transcriptional gene silencing. Recent evidence has demonstrated that specific miRNAs are involved in the pathological development of PAD. In this review, the roles of specific miRNAs in PAD are summarized.
Insights
Peripheral arterial disease (PAD) involves atherosclerosis and abnormal cell growth. This review summarizes how microRNAs (miRNAs) contribute to PAD development and progression.
Area of Science:
- Vascular Biology
- Molecular Medicine
- Genetics
Background:
- Peripheral arterial disease (PAD) is a manifestation of systemic atherosclerosis.
- PAD pathology involves abnormal vascular smooth muscle cell proliferation and neointimal hyperplasia.
- MicroRNAs (miRNAs) are key regulators of gene expression with roles in cardiovascular diseases.
Purpose of the Study:
- To review the specific roles of microRNAs (miRNAs) in the pathogenesis of peripheral arterial disease (PAD).
- To highlight the molecular mechanisms by which miRNAs influence PAD development.
Main Methods:
- Literature review of studies investigating miRNA involvement in PAD.
- Analysis of research on miRNA regulation of vascular smooth muscle cell proliferation and neointimal lesion formation.
Main Results:
- Specific miRNAs have been identified as critical players in the pathological processes underlying PAD.
- miRNAs modulate key pathways involved in vascular remodeling and inflammation in PAD.
Conclusions:
- MicroRNAs represent significant therapeutic targets for managing peripheral arterial disease (PAD).
- Further research into miRNA function can lead to novel strategies for PAD treatment.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
